Castle Biosciences, Inc. (NAS: CSTL) Stock Analysis & Fundamentals | ScreenerHero

Create free account

CSTLCastle Biosciences, Inc.

NAS · US · Healthcare · Diagnostics & Research · castlebiosciences.com

24.23USD+0.87%Mkt Cap: 734.89M $P/E: —1d ago

Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The compan…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.26BUSDP/E 43.7

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.21BUSDP/E 27.6

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.40BUSDP/E 22.0

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.73BUSDP/E 26.3

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.70BUSDP/E 43.3

GeneDx Holdings Corp.

Personalis, Inc.

Diagnostyka S.A.

$1.46BUSDP/E 22.1

Clínica Baviera, S.A.

$996.45MUSDP/E 20.9

OPKO Health, Inc.

$653.57MUSDP/E 42.6

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$292.59MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap734.89M $

Enterprise Value503.56M $

Revenue (TTM)339.92M $

Gross Profit273.20M $

Net Income (TTM)-24.16M $

Revenue/Share11.60 USD

Last Price24.23 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees942

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-25.33

PEG—

EV/EBITDA-27.44

EV/Revenue1.48

P/S2.16

P/B1.59

EPS (TTM)-0.42

EPS (Forward)-0.96

52W Range

14.5932% of range44.28

52W High44.28 USD

52W Low14.59 USD

Profitability

Gross Margin79.37%

Oper. Margin-22.00%

EBITDA Margin-5.40%

Profit Margin-7.02%

ROE-5.13%

ROA-4.18%

Growth

Revenue Growth-4.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF64.35M $

CapEx (TTM)36.02M $

FCF Margin3.79%

FCF Yield1.75%

Net Debt-224.96M $

Net Debt/EBITDA12.26

Balance Sheet

Debt/Equity0.08

Current Ratio6.75

Quick Ratio6.26

Book Value/Sh15.23 USD

Cash/Share8.628 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.0 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)42.78 USD

Upside (mean)+76.5%

Target Range35.00 USD – 52.00 USD

$35.00+76.5% to mean$52.00

# Analysts9

Ownership

Shares Out.30.33M

Float26.79M

Insiders2.73%

Institutions92.43%

Short Interest

Short Ratio4.0d

Short % Float5.04%

Short % Out.4.92%

Shares Short1.49M

Short (prev mo.)1.48M

Technical

SMA 5021.61 (+12.1%)

SMA 20028.74 (-15.7%)

Beta1.00

S&P 52W Chg20.25%

Avg Vol (30d)304.55K

Avg Vol (10d)252.96K

Technical Indicators

RSI (14)59.3

MACD0.6507

MACD Signal0.6511

MACD Hist.-0.0003

BB Upper25.97 USD

BB Middle23.07 USD

BB Lower20.17 USD

BB Width25.18%

ATR (14)1.023 USD

Vol Ratio (20d)1.14x